Register for the EUnetCCC Precision Cancer Diagnostics Webinar #2: Advancing Data Collection in Molecular Tumour Board Operations

A collaborative effort to standardise cancer diagnostics

The EUnetCCC Precision Cancer Diagnostics Working Group, together with the EUnetCCC Secondary Use of Clinical Data Working Group will host the second installment of the open webinar series dedicated to the Harmonisation and Implementation of Molecular Tumour Board (MTB) Operations. This upcoming session, scheduled for 19 September 2025, will highlight the critical theme of data collection within MTB processes.

The webinar will bring together leading experts, stakeholders, and innovators in the field of precision cancer diagnostics to discuss best practices, challenges, and solutions for collecting and managing clinical and genomic data in Comprehensive Cancer Centres (CCCs) across Europe. The event underscores the growing consensus that harmonised data collection is essential for advancing personalised cancer care, facilitating research, and improving patient outcomes.

Key details

Date and time: 19 September 2025, 14:00 - 16:00 CEST

Format: Microsoft Teams meeting

Target audience: Professionals and stakeholders involved in cancer care, research, data management, and policy development

Register here: Advancing Data Collection in Molecular Tumour Board Operations

Agenda highlights

The session will open with a presentation by Live Fagereng and Elin Naderi, outlining EUnetCCC's strategy to promote harmonised data collection from MTBs within CCCs. This will be followed by a series of expert talks, including:

• 1+ Million Genomes (1+MG) minimal dataset for cancer: Giovanni Tonon will discuss efforts to define a minimal dataset for cancer, leveraging insights from the ambitious 1+ Million Genomes (1+MG) initiative
• Data collection in the AcSe program (France): Christophe Le Tourneau will share experiences and lessons learned from the AcSe program in France, which has pioneered structured data collection in clinical oncology.
• Merging data from PCM trials in PRIME-ROSE: Kjetil Tasken will explore how the PRIME-ROSE project accelerated knowledge output through sharing and merging data from precision cancer medicine trials in Europe.
• Platform for data merging in Europe (JA-PCM): Paolo Marchetti will present the development of a pan-European platform designed to facilitate the merging and analysis of clinical and genomic data.
• Stakeholder engagement and open discussion: A dedicated segment will invite comments from key stakeholders, including payers, industry regulators, and patient representatives, to emphasise the importance of multi-sector collaboration in shaping the future of MTB operations. The session will conclude with an open dialogue, offering attendees the opportunity to raise questions, share perspectives, and actively contribute to the conversation.

We look forward to welcoming you to this second installment of the webinar series to build an active community shaping the future of precision cancer diagnostics.

Join the EUnetCCC Task 8.2.4 Precision Diagnostics Mailing List and the EUnetCCC Task 8.2.5 Secondary Use of Clinical Data Mailing List to get the latest news and updates from our team.